Strides Pharma Science share price
You have to be logged in to add this to Watchlist.Strides Pharma Science is trading -5.63% lower at Rs 1,419.15 as compared to its last closing price. Strides Pharma Science has been trading in the price range of 1,529.80 & 1,394.05. Strides Pharma Science has given 131.69% in this year & 8.31% in the last 5 days.
Strides Pharma Science has TTM P/E ratio 72.64 as compared to the sector P/E of 33.29.There are 2 analysts who have initiated coverage on Strides Pharma Science. There are 1 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0 analysts have given the stock a sell rating.
The company posted a net profit of 93.23 Crores in its last quarter.
Listed peers of Strides Pharma Science include Marksans Pharma (2.32%), Sanofi India (1.97%), Strides Pharma Science (-5.63%) etc.
Strides Pharma Science has a 74.16% public holding.The Mutual Fund holding in Strides Pharma Science was at 10.80% in 30 Sep 2024. The MF holding has increased from the last quarter. The FII holding in Strides Pharma Science was at 30.08% in 30 Sep 2024. The FII holding has increased from the last quarter.
Strides Pharma Science share price range
|
| ||||
|
| ||||
Strides Pharma Science share Key Metrics
| Market Cap ( ₹ Cr.) | 13,832.81 | ||||||||||||||||||
|
|
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Strides Pharma Science Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 24-Oct-24 | Quarterly Results |
| 29-Jul-24 | Quarterly Results |
| 22-May-24 | Audited Results & Final Dividend |
| 30-Jan-24 | Quarterly Results |
| 30-Oct-23 | Quarterly Results |
| 25-Sep-23 | Scheme of Arrangement |
| 02-Aug-23 | Quarterly Results |
| 25-May-23 | Audited Results & Final Dividend |
| 24-Jan-23 | Quarterly Results |
| 14-Nov-22 | Quarterly Results |
| Meeting Date | Announcement On | Purpose |
| 10-Sep-24 | 08-Aug-24 | COM |
| 28-Aug-23 | 25-May-23 | AGM |
| 28-Jul-23 | 26-Jun-23 | POM |
| 24-Mar-23 | 20-Feb-23 | POM |
| 06-Feb-23 | 13-Jan-23 | EGM |
| 09-Sep-22 | 24-May-22 | AGM |
| 07-Apr-22 | 17-Feb-22 | EGM |
| 03-Sep-21 | 26-Jul-21 | AGM |
| 13-Jun-21 | 12-May-21 | POM |
| 17-Mar-21 | 10-Feb-21 | POM |
| Announcement On | Record Date | Ex-Dividend | Dividend Value |
| 22-May-24 | 09-Sep-24 | 09-Sep-24 | 2.5 |
| 21-Jul-23 | 04-Aug-23 | 04-Aug-23 | 1.5 |
| 27-May-21 | 06-Aug-21 | 05-Aug-21 | 2.5 |
FAQs about Strides Pharma Science share price
Strides Pharma Science is trading at 1419.15 as on Mon Nov 25 2024 10:17:42. This is -5.63% lower as compared to its previous closing price of 1503.75.
The market capitalization of Strides Pharma Science is 13832.81 Cr as on Mon Nov 25 2024 10:17:42.
The average broker rating on Strides Pharma Science is Strong Buy. The breakup of analyst rating is given below -
- 1 analysts have given a strong buy rating
- 1 analysts have given a buy rating
- 0 analysts have given a hold rating
- 0 analysts have given a sell rating
- 0 analysts have given a strong sell rating
The 52 wk high for Strides Pharma Science is 1675.25 whereas the 52 wk low is 482.50
Strides Pharma Science can be analyzed on the following key metrics -
- TTM P/E: 72.64
- Sector P/E: 33.29
- Dividend Yield: 0.17%
- D/E ratio: 1.02
Strides Pharma Science reported a net profit of -70.61 Cr in 2024.
Strides Pharma Science Quick Links
Strides Pharma Science Dividend Strides Pharma Science Bonus Strides Pharma Science News Strides Pharma Science AGM Strides Pharma Science Rights Strides Pharma Science Splits Strides Pharma Science Board Meetings Strides Pharma Science Key Metrics Strides Pharma Science Shareholdings Strides Pharma Science Profit Loss Strides Pharma Science Balance Sheet Strides Pharma Science Cashflow Strides Pharma Science Q1 Results Strides Pharma Science Q2 Results Strides Pharma Science Q3 Results Strides Pharma Science Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks